← Eichor
Condition: Hidradenitis Suppurativa Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hidradenitis Suppurativa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativ
Phase 1 · 21 location(s) · Incyte Corporation · NCT07049575Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169Radiotherapy for Refractory Hidradenitis Suppurativa
NA · 2 location(s) · Thomas Jefferson University · NCT07414550An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Phase 3 · 4 location(s) · Novartis Pharmaceuticals · NCT07665437Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
Phase 3 · 4 location(s) · Institut Pasteur · NCT05821478Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis S
Phase 2 · 30 location(s) · Incyte Corporation · NCT07213973A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moder
Phase 2 · 2 location(s) · AbbVie · NCT06524635A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
Phase 2 · 4 location(s) · Tulane University · NCT07077902A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
Phase 1 · 1 location(s) · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · NCT06082323Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
Phase N/A · 1 location(s) · Peking Union Medical College · NCT07109765The Safety and Efficacy of Roflumilast Foam in HS
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07263230Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adul
Phase N/A · 16 location(s) · Novartis Pharmaceuticals · NCT07543419A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Phase 2/Phase 3 · 58 location(s) · Bluefin Biomedicine, Inc. · NCT07287644A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®
Phase 1 · 14 location(s) · UCB Biopharma SRL · NCT06888193Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
NA · 1 location(s) · Wayne State University · NCT04218422A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo
Phase N/A · 116 location(s) · AbbVie · NCT07136467Real-world Secukinumab Outcomes in Canadian HS Patients
Phase N/A · 15 location(s) · Novartis Pharmaceuticals · NCT07282015A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · 49 location(s) · Takeda · NCT07244263Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Phase 2 · 1 location(s) · Sinocelltech Ltd. · NCT07244510Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
EARLY_Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT06326476Evolution and Treatments of Chronic Inflammatory Systemic Diseases
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT04191395A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Phase 2 · 41 location(s) · Navigator Medicines, Inc. · NCT07384975Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Phase 2 · 79 location(s) · Sanofi · NCT07170917Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
Phase 4 · 7 location(s) · Novartis Pharmaceuticals · NCT07489573A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T
Phase N/A · 10 location(s) · Sonoma Biotherapeutics, Inc. · NCT07123038Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT05507125Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
Phase N/A · 1 location(s) · University of California, San Francisco · NCT04115566Myriad™ Augmented Soft Tissue Reconstruction Registry
Phase N/A · 15 location(s) · Aroa Biosurgery Limited · NCT05243966Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
EARLY_Phase 1 · 1 location(s) · Virginia Clinical Research, Inc. · NCT06645821
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.